Kintara Therapeutics Inc. buy yester
Start price
16.11.20
/
50%
€1.35
Target price
16.11.21
€1.00
Performance (%)
-45.11%
End price
17.11.21
€0.74
Summary
This prediction ended on 17.11.21 with a price of €0.74. Massive losses of -45.11% were the result for the BUY prediction by yester. yester has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Kintara Therapeutics Inc. | - | - | - | - |
| iShares Core DAX® | 1.804% | -0.748% | 13.168% | 16.408% |
| iShares Nasdaq 100 | -0.182% | -3.412% | 39.976% | 43.502% |
| iShares Nikkei 225® | 0.413% | -7.381% | 18.776% | 2.874% |
| iShares S&P 500 | 0.664% | -1.941% | 28.141% | 42.155% |
According to yester what are the pros and cons of Kintara Therapeutics Inc. for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Future proof or reliable business model
Cons
Comments by yester for this prediction
In the thread Delmar Pharmaceuticals Inc. diskutieren
In the thread Trading Delmar Pharmaceuticals Inc.
Die von yester gewählte maximale Laufzeit wurde überschritten